Bruker Corporation 2023 Investor Day: Proteomics Spatial Biology

Bruker Corporation's June 2023 investor day presentation focusing on strategic initiatives in proteomics and spatial biology. The event featured leadership discussions on drug discovery services, mass spectrometry innovations, cell microscopy, and in-vivo neuroscience research, with a medium-term outlook through 2026.